title: [Management of side effects of targeted therapies in renal cancer: stomatological side effects (mucositis, epistaxis)].
abstract: The advent of targeted therapies in the treatment of renal cancer has shown different types of lesions of the oral cavity, which appear to be specific to the drug classes used (mTOR inhibitors, anti-angiogenic agents and conventional cytotoxic drugs). Before starting treatment with targeted therapy, it is essential to have an oral and a dental examination. The treatment of mucositis induced by targeted therapies is based on bicarbonate-based mouthwash, with the optional addition of an antifungal or a local antiseptic. It is possible to use topical or systemic analgesics for the pain. Dietary advice for patients is also useful. Most cases of epistaxis caused by anti-angiogenics stop spontaneously and require no medical intervention. Regular application of an emollient can be used to prevent the formation of scabs.
authors.affiliation: CHU de la Pitié-Salpêtrière, service de stomatologie et chirurgie maxillofaciale, 47-83, boulevard de l'Hôpital, 75651 Paris Cedex 13, France. Electronic address: scarlette.agbo-godeau@psl.aphp.fr.
authors.forename: Scarlette
authors.initials: S
authors.lastname: Agbo-Godeau
authors.affiliation: Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Nicolas-Virelizier
authors.affiliation: CHU HEGP, service d'oncologie médicale, 20, rue Leblanc, 75908 Paris Cedex 15, France.
authors.forename: Florian
authors.initials: F
authors.lastname: Scotté
keywords: angiogenesis; angiogenèse; epistaxis; mTOR; mucites; mucositis; épistaxis